# Percutaneous Intervention Versus Surgery in the Treatment of Common Femoral Artery Lesions

Study · id `cardio:ct-nct02517827` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02517827](<https://clinicaltrials.gov/study/NCT02517827>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02517827

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 306 participants.

## Technical summary

Registry record NCT02517827. Randomized; no masking; primary purpose treatment. Start 2017-08-01 (actual); primary completion 2019-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 306 participants (planned count; ClinicalTrials.gov record NCT02517827, source copy `cardio:ctgov-nct02517827-2018-08-03`, retrieved 2026-10-31)
- Started: 2017-08-01 (actual) (ClinicalTrials.gov record NCT02517827, source copy `cardio:ctgov-nct02517827-2018-08-03`, retrieved 2026-10-31)
- Primary completion: 2019-12 (anticipated) (ClinicalTrials.gov record NCT02517827, source copy `cardio:ctgov-nct02517827-2018-08-03`, retrieved 2026-10-31)
- Completion: 2021-12 (anticipated) (ClinicalTrials.gov record NCT02517827, source copy `cardio:ctgov-nct02517827-2018-08-03`, retrieved 2026-10-31)
- Countries: Germany (ClinicalTrials.gov record NCT02517827, source copy `cardio:ctgov-nct02517827-2018-08-03`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02517827-2018-08-03`, retrieved 2026-10-31)

## The registry's words

- Brief title: Percutaneous Intervention Versus Surgery in the Treatment of Common Femoral Artery Lesions
- Acronym: PESTO-AFC
- Condition: Peripheral Artery Disease
- Condition: Artery Stenosis
- Intervention (Device): Atherectomy and paclitaxel-coated balloon angioplasty
- Intervention (Procedure): Open, surgical endarterectomy
- Lead sponsor: Herz-Zentrums Bad Krozingen
- Lead sponsor class: OTHER
- Collaborator: Medtronic
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as a collaborator: Medtronic (`cardio:medtronic`)

## Provenance

Content hash: 48e488e5f18a73999dbed23a5f190e6f9e2228d5598d1f63da5b83893e1d4799
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
